TrialHuman vaccines & immunotherapeutics2022

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.

Xiaoqiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.